November 15, 2011 – Stand Up To Cancer (SU2C) and KWF Kankerbestrijding (Dutch Cancer Society), along with the American Association for Cancer Research, call upon the cancer research community to submit applications for Sta Op Tegen Kanker International Translational Cancer Research Grants.
One or two Sta Op Tegen Kanker International Translational Cancer Research Grants will be awarded for a total funding of €2.4 million (US$3.3 million, at the current exchange rate). The grants provide four years of funding for translational cancer research projects that address critical problems in patient care, including prevention strategies for those at risk, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional team of expert investigators. Projects must be designed to accelerate the application of new preventive, diagnostic or therapeutic agents to the clinic, and may focus on particular organ sites or on specialized research areas.
Proposals for Sta Op Tegen Kanker International Translational Cancer Research Grants must describe plans indicating how the work will be translated into the clinic. To maximize creativity, innovation and collaboration, the projects will span multiple disciplines and use modern biological tools to attack research questions in a coordinated way.
The principal investigator of each project must be from a research institute located in The Netherlands. Co-principal investigators can be from research institutes in any country. Each project must include at least two research institutes located in The Netherlands and at least one research institute outside The Netherlands. At least fifty percent (50%) of the grant must be allocated to research executed in The Netherlands.
Since the launch of Stand Up To Cancer in 2008, the AACR has played an integral role as SU2C’s scientific partner by providing scientific leadership, expert peer review and grants administration. The AACR will work closely with the Dutch Cancer Society on this project. The Dutch Cancer Society will review the proposals for the Sta Op Tegen Kanker International Translational Research projects in cooperation with the Stand Up To Cancer Scientific Advisory Committee. The Dutch Cancer Society and the committee consist of highly accomplished senior laboratory researchers and physician-scientists who are respected internationally for their own accomplishments in cancer research and as leaders in the field.
The Sta Op Tegen Kanker International Translational Cancer Research Grants are supported with money raised in connection with a Nov. 10, 2010, Dutch version of the Stand Up To Cancer televised fundraising event, broadcast in The Netherlands in cooperation with the Dutch Cancer Society (KWF Kankerbestrijding).
Proposals for Sta Op Tegen Kanker International Translational Cancer Research projects must be submitted by Nov. 1, 2011. For general information on eligibility criteria, the application process and other details about this Dream Team grant, click here. Inquiries may be directed to poz@kwfkankerbestrijding.nl.
The Sta Op Tegen Kanker International Translational Cancer Research Grant Dream Team(s) will be notified on Feb. 22, 2012, and the announcement will be made public on Feb. 29. There will be an additional public announcement at the AACR Annual Meeting 2012, held March 30 through April 4 at McCormick Place in Chicago, Ill.
# # #
About Stand Up To Cancer
Stand Up To Cancer (SU2C) – a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization – raises funds to accelerate the pace of groundbreaking translational research that can get new therapies to patients quickly and save lives. SU2C facilitates collaboration among the best and the brightest in the cancer research community. By galvanizing the entertainment industry, SU2C generates awareness and builds grassroots support for this effort.
To view the recently televised Stand Up To Cancer fundraising special, please visit: www.su2c.org/2010show. For general information, please visit www.su2c.org.
About the Entertainment Industry Foundation
Stand Up To Cancer is a program of the Entertainment Industry Foundation (EIF), the 501(c)(3) not-for-profit organization that serves as the collective philanthropy for the television and film businesses. EIF has distributed hundreds of millions of dollars to support programs addressing critical health, education and social issues.
About the Dutch Cancer Society
The Dutch Cancer Society is a nation-wide organisation for cancer-related work in the Netherlands. We spend 80% of our budget to finance cancer research; 20% is spent on public awareness and information, prevention and patient support programmes. The DCS’ headquarters is located in Amsterdam; our professional staff amount to 140 persons. Over 120.000 volunteers support the Dutch Cancer Society whether it comes to local or nation-wide fundraising, scientific or policy advice in several councils and committees. We rely on nearly 1600 local committees that organise our yearly door-to-door campaign to
raise funds for the fight against cancer (yearly revenue around € 8 million). The Dutch Cancer Society is supported by 800.000 donors. We receive no government money.
About the American Association for Cancer Research
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 laboratory, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards to young investigators, and it also funds cutting-edge research projects conducted by senior researchers. The AACR has numerous fruitful collaborations with organizations and foundations in the U.S. and abroad, and functions as the scientific partner of Stand Up To Cancer, a charitable initiative that supports groundbreaking research aimed at getting new cancer treatments to patients in an accelerated time frame. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care, and educational workshops are held for the training of young cancer investigators. The AACR publishes seven major peer-reviewed journals: Cancer Discovery; Cancer Research; Clinical Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Prevention Research. In 2010, AACR journals received 20 percent of the total number of citations given to oncology journals. The AACR also publishes Cancer Today, a magazine for cancer patients, survivors and their caregivers, which provides practical knowledge and new hope for cancer survivors. A major goal of the AACR is to educate the general public and policymakers about the value of cancer research in improving public health, the vital importance of increases in sustained funding for cancer research and biomedical science, and the need for national policies that foster innovation and the acceleration of progress against the 200 diseases we call cancer.
Visit the AACR: www.aacr.org
Follow the AACR on Twitter: @aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
Media Contact:
Michele Sharp
(267) 646-0622
Michele.Sharp@aacr.org